NCT01279720View on ClinicalTrials.gov

Gene Therapy ADA Deficiency

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Adenosine Deaminase Deficiency
Interventions
BIOLOGICAL

Intravenous infusion of transduced cells

Intravenous infusion of transduced cells

Trial Locations (1)

WC1N 1EH

Great Ormond Street Hospital for Children NHS Trust, London

All Listed Sponsors
lead

Great Ormond Street Hospital for Children NHS Foundation Trust

OTHER

NCT01279720 - Gene Therapy ADA Deficiency | Biotech Hunter | Biotech Hunter